A detailed history of Snowden Capital Advisors LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 29,366 shares of ZTS stock, worth $4.8 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
29,366
Previous 29,266 0.34%
Holding current value
$4.8 Million
Previous $5.07 Million 13.09%
% of portfolio
0.17%
Previous 0.15%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$172.58 - $196.48 $17,258 - $19,648
100 Added 0.34%
29,366 $5.74 Million
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $51,230 - $62,948
352 Added 1.22%
29,266 $5.07 Million
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $123,921 - $149,555
748 Added 2.66%
28,914 $4.89 Million
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $150,379 - $198,689
-993 Reduced 3.41%
28,166 $5.56 Million
Q3 2023

Nov 14, 2023

SELL
$167.14 - $192.77 $211,933 - $244,432
-1,268 Reduced 4.17%
29,159 $5.07 Million
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $209,382 - $242,285
-1,301 Reduced 4.1%
30,427 $5.24 Million
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $299,397 - $360,191
2,058 Added 6.94%
31,728 $5.28 Million
Q4 2022

Feb 13, 2023

SELL
$131.14 - $157.47 $31,735 - $38,107
-242 Reduced 0.81%
29,670 $4.35 Million
Q3 2022

Nov 09, 2022

BUY
$148.29 - $182.55 $344,329 - $423,881
2,322 Added 8.42%
29,912 $4.44 Million
Q2 2022

Aug 12, 2022

BUY
$155.97 - $200.09 $1.76 Million - $2.26 Million
11,311 Added 69.48%
27,590 $4.74 Million
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $889,355 - $1.15 Million
4,903 Added 43.1%
16,279 $3.07 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $2.2 Million - $2.81 Million
11,376 New
11,376 $2.78 Million
Q3 2021

Feb 05, 2024

SELL
$189.29 - $209.69 $2.66 Million - $2.95 Million
-14,061 Reduced 48.22%
15,098 $2.93 Billion
Q2 2021

Jan 08, 2024

BUY
$155.9 - $187.99 $50,511 - $60,908
324 Added 2.13%
15,517 $2.89 Billion
Q1 2021

Jan 08, 2024

BUY
$144.0 - $169.39 $201,024 - $236,468
1,396 Added 10.12%
15,193 $2.39 Billion
Q4 2020

Jan 08, 2024

SELL
$157.07 - $174.35 $2.88 Million - $3.19 Million
-18,311 Reduced 57.03%
13,797 $2.28 Billion
Q3 2020

Jan 08, 2024

BUY
$137.1 - $165.37 $31,670 - $38,200
231 Added 0.72%
32,108 $5.31 Billion
Q2 2020

Jan 08, 2024

BUY
$111.92 - $142.53 $1.12 Million - $1.42 Million
9,967 Added 45.49%
31,877 $4.37 Billion
Q1 2020

Jan 08, 2024

BUY
$92.66 - $144.94 $773,247 - $1.21 Million
8,345 Added 61.52%
21,910 $2.58 Billion
Q4 2019

Jan 30, 2024

BUY
$116.25 - $133.25 $28,132 - $32,246
242 Added 1.82%
13,565 $1.8 Billion
Q4 2019

Jan 08, 2024

BUY
$116.25 - $133.25 $28,132 - $32,246
242 Added 1.82%
13,565 $1.8 Billion
Q3 2019

Jan 30, 2024

SELL
$112.57 - $128.43 $6,979 - $7,962
-62 Reduced 0.46%
13,323 $1.66 Billion
Q3 2019

Jan 08, 2024

BUY
$112.57 - $128.43 $850,353 - $970,160
7,554 Added 130.94%
13,323 $1.66 Billion
Q2 2019

Jan 30, 2024

SELL
$97.98 - $114.28 $1.55 Million - $1.8 Million
-15,774 Reduced 54.1%
13,385 $1.52 Billion
Q2 2019

Jan 08, 2024

SELL
$97.98 - $114.28 $733,184 - $855,157
-7,483 Reduced 56.47%
5,769 $1.52 Billion
Q1 2019

Jan 08, 2024

BUY
$81.56 - $100.67 $96,322 - $118,891
1,181 Added 9.78%
13,252 $1.33 Billion
Q4 2018

Jan 08, 2024

BUY
$79.28 - $95.27 $230,070 - $276,473
2,902 Added 31.65%
12,071 $1.03 Billion
Q3 2018

Jan 08, 2024

BUY
$83.5 - $93.23 $72,645 - $81,110
870 Added 10.48%
9,169 $840 Million
Q2 2018

Jan 08, 2024

BUY
$79.9 - $89.2 $61,922 - $69,130
775 Added 10.3%
8,299 $707 Million
Q1 2018

Jan 08, 2024

BUY
$71.51 - $84.69 $264,730 - $313,522
3,702 Added 96.86%
7,524 $628 Million
Q4 2017

Jan 08, 2024

BUY
$63.24 - $72.8 $15,177 - $17,472
240 Added 6.7%
3,822 $275 Million
Q3 2017

Jan 08, 2024

BUY
$59.73 - $65.4 $213,952 - $234,262
3,582 New
3,582 $228 Million
Q2 2017

Jan 08, 2024

SELL
N/A
-4,273 Closed
0 $0
Q1 2017

Jan 08, 2024

SELL
N/A
-24,886
4,273 $228 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $76.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.